According to PricewaterhouseCoopers, merger and acquisition activity in the medtech sector posted more deals in Q3 than in Q2. The consolidation trend in pharma and life sciences was especially evident in medical devices. To find out why, click here: http://www.massdevice.com/news/medtech-mergers-stayed-strong-q3